Clearbridge Investments

Why the Health Care Rebound Has Staying Power

Informações:

Sinopsis

ClearBridge Investment Strategist Jeffrey Schulze, CFA joins ClearBridge health care analysts Marshall Gordon and Nicholas Wu, PhD to analyze drug pricing narratives and the health care M&A landscape, discuss opportunities created by innovation in biopharma, and highlight health care opportunities abroad.